Sanofi SA logo

Sanofi SA

SNY
Healthcare|Drug Manufacturers - General|France
$43.50
-0.40 (-0.91%)
DCF (FCF)
$57.37
Tangible Book
$1.80
Graham Number
$12.04
Earnings Power
$35.15

Clinical Trials (501)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT05983068
A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis
Dermatitis Atopic
P4
Active48Open-labeldupilumab
NCT06101095
A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)
Eosinophilic Oesophagitis
P4
Active69RCT, Double-blindDupilumab, Placebo
NCT07412470
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Kidney Transplant Rejection
P2P3
Recruiting526RCT, Open-labelFrexalimab, Frexalimab, Tacrolimus, rabbit anti-thymocyte globulin, mycophenolate mofetil, mycophenolate sodium, methylprednisolone, prednisone
NCT06191315
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Wheezing, Asthma
P3
Recruiting90RCT, Double-blindDupilumab, Placebo
NCT07112378
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE)
P3
Recruiting20RCT, Single-blinddupilumab
NCT04934475
MInimal Residual Disease Adapted Strategy
Multiple Myeloma
P3
Active791RCT, Open-labelIsatuximab
NCT07086976
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
Autoimmune Haemolytic Anaemia
P3
Recruiting90RCT, Double-blindrilzabrutinib, placebo
NCT06143891
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
Chronic Graft Versus Host Disease
P3
Active260RCT, Double-blindBelumosudil, Placebo, Prednisone, Prednisolone
NCT07285460
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Hemophilia
P3
Recruiting85Open-labelFitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate (ATIIIC)
NCT06838000
Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents
Pneumococcal Infections
P3
Active1,268RCT, Single-blindPCV21, 20vPCV
NCT06290128
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
P3
Recruiting140RCT, Double-blindRiliprubart, Placebo, Riliprubart, Placebo
NCT06082037
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Lung Transplant Rejection
P3
Recruiting180RCT, Double-blindBelumosudil, Azithromycin, Placebo
NCT06372145
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis
P3
Active2,500Open-labelTolebrutinib, Placebo, Teriflunomide
NCT06647407
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
Meningococcal Immunization, Healthy Volunteers
P1P2
Active750RCT, Double-blindPentavalent Meningococcal ABCYW vaccine, MenACYW conjugate vaccine, MenACYW conjugate vaccine, Meningococcal group B vaccine, Paracetamol, DTap-HepB-IPV-Hib vaccine, DTap-HepB-IPV-Hib vaccine, DTap-HepB-IPV-Hib vaccine, Rotavirus vaccine, Pneumococcal 13-valent conjugate vaccine
NCT05996627
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Chronic Graft Versus Host Disease
P2
Recruiting82RCT, Double-blindBelumosudil, Placebo Administration
NCT06356571
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Plasma Cell Myeloma Refractory
P2
Recruiting64Open-labelIsatuximab SC-OBDS, Montelukast, Dexamethasone, Acetaminophen, Diphenhydramine, Methylprednisolone, Carfilzomib
NCT05346809
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
Lymphoma, Multiple Myeloma
P2
Recruiting39RCT, Open-labelIsatuximab
NCT02991469
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
Juvenile Idiopathic Arthritis
P2
Recruiting51Open-labelSarilumab SAR153191 (REGN88)
NCT04558931
Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma
Multiple Myeloma
P2
Recruiting62RCT, Open-labelCellProtect, Isatuximab
NCT07547436
A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
P2
Recruiting70RCT, Double-blindSAR445399, Placebo
NCT07479979
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
Relapse Multiple Myeloma, Refractory Multiple Myeloma
P1P2
Recruiting62Open-labelSelinexor, Carfilzomib, Isatuximab, Dexamethasone
NCT06686654
Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older
Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization
P1P2
Active1,530RCT, Double-blindInvestigational hMPV/RSV vaccine, Investigational hMPV vaccine (monovalent), Investigational RSV vaccine (monovalent), Licensed RSV Vaccine, Placebo, Investigational RSV+hMPV vaccine
NCT06557772
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
Coeliac Disease, Celiac Disease
P2
Active229RCT, Double-blindAmlitelimab, Placebo
NCT07225569
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
P2
Recruiting144RCT, Double-blindSAR445399, Placebo
NCT05669989
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Plasma Cell Myeloma
P2
Active70Open-labelIsatuximab intravenous (IV), Cemiplimab (SAR439684), Dexamethasone, Lenalidomide, Pomalidomide, Isatuximab subcutaneous (SC), Carfilzomib
NCT05704049
A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
P2
Active118RCT, Open-labelIsatuximab, Carfilzomib, Dexamethasone, Dexamethasone IV, Montelukast, Acetaminophen, Diphenhydramine, Methylprednisolone
NCT05011123
Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia
Yellow Fever
P2
Active690RCT, Double-blindYellow fever vaccine (produced on serum-free Vero cells), Yellow fever vaccine
NCT06392477
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma
B-cell Non Hodgkin Lymphoma
P1
Recruiting96Open-labelSAR448501
NCT07629336
SAR447971 First-in-human Study
Hidradenitis, Healthy Volunteers
P1
Recruiting114RCT, Double-blindSAR447971, Placebo
NCT07295028
Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults
Lower Respiratory Tract Disease, Healthy Participants
P1
Active240RCT, Double-blindtrivalent (RSV/hMPV/PIV3) vaccine candidate, trivalent (RSV/hMPV/PIV3) vaccine candidate, trivalent (RSV/hMPV/PIV3) vaccine candidate, bivalent (RSV/hMPV) unlicensed comparator, monovalent (RSV) unlicensed comparator, Biological/Vaccine: monovalent (hMPV) unlicensed comparator, monovalent (PIV3) unlicensed comparator
NCT07316114
A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria
Recruiting400Dupilumab
NCT04657783
French National Cohort of People With Type 1 Diabetes
Diabetes Mellitus, Type 1, Cardiovascular Diseases
Recruiting15,000
NCT03428646
Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
Dermatitis, Atopic
Active858Dupilumab
NCT03549416
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
Atopic Dermatitis
Recruiting1,200
NCT00196742
Fabry Disease Registry & Pregnancy Sub-registry
Fabry Disease
Recruiting9,000
NCT07457580
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Type 1 Diabetes
Recruiting60Teplizumab
NCT00567073
Pompe Pregnancy Sub-Registry
Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset)
Recruiting20
NCT07290803
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
Recruiting1,000
NCT03402919
Comprehensive Assessment of Neurodegeneration and Dementia
Dementia, Mild Cognitive Impairment (MCI)
Recruiting1,573
NCT07118306
COPD Exacerbation Follow Up
COPD (Chronic Obstructive Pulmonary Disease)
Recruiting485
NCT04743609
RSV Burden in Outpatient and Hospital Settings
RSV Infection, Children, Only
N/A
Recruiting1,900Open-label
NCT04113330
Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia
Dengue Fever
Active918
NCT06393946
Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France
Chronic Rhinosinusitis With Nasal Polyposis
Active150Dupilumab
NCT07380711
Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
Chronic Obstructive Pulmonary Disease COPD
Recruiting500
NCT06258057
Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy
Pertussis (Whooping Cough)
Active365,000
NCT00402441
Risedronate in the Prevention of Osteoporosis in Postmenopausal Women
Osteoporosis, Postmenopausal
P4
Completed260RCT, Double-blindRisedronate (HMR4003)
NCT01307865
Volume Restoration of the Aging Midface With Sculptra Aesthetic
Problem of Aging
P4
Completed15Open-labelinjectable poly-L-lactic acid
NCT01436539
Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients
Chronic Hepatitis B
P4
Unknown300RCT, Open-labelAdefovir Dipivoxil and polyene phosphatidylcholine, Adefovir Dipivoxil
NCT00362037
I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
Hypertension
P4
Completed281Open-labelIrbesartan (Aprovel)
NCT00708344
ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination
Hypertension
P4
Completed832RCT, Open-labelIrbesartan - Hydrochlorothiazide, Irbesartan - Hydrochlorothiazide
NCT00549965
Satisfaction and Compliance of Risedronate in PMO
Osteoporosis, Postmenopausal
P4
Completed202RCT, Open-labelRisedronate Sodium
NCT00174681
Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P4
Completed390RCT, Open-labelInsulin Glargine
NCT00304265
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
Pertussis, Diphtheria
P4
Completed215RCT, Open-labelCOVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®)
NCT00230607
Study of the Effects of Fabrazyme Treatment on Lactation and Infants
Fabry Disease, Alpha Galactosidase A Deficiency
P4
Terminated7Open-labelagalsidase beta
NCT02831608
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis
Myocardial Infarction, Influenza, Human
P4
Completed2,571RCT, Double-blindInfluenza vaccine, Placebo
NCT00835926
A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination
Influenza
P4
Completed121Open-labelInfluenza virus vaccine, Influenza virus vaccine
NCT00347958
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
Tetanus, Diphtheria
P4
Completed545Open-labelTetanus-diphtheria-acellular pertussis (Tdap) vaccine
NCT01278433
A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China
Polio, Poliomyelitis
P4
Completed5,007Open-labelIMOVAX Polio™: Inactivated Poliomyelitis Vaccine
NCT00547768
Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.
Allergy
P4
Completed36RCT, Double-blindFexofenadine HCI
NCT03389893
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
Atopic Dermatitis (AD)
P4
Terminated72RCT, Double-blindDupilumab, Placebo
NCT00917436
Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain
Low Back Pain
P4
Completed183Thiocolchicoside
NCT00636870
Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine
Allergic Rhinitis
P4
Completed220RCT, Double-blindFexofenadine
NCT04980027
Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs
Type 2 Diabetes Mellitus
P4
Completed228Open-labelInsulin glargine (U300)
NCT02842359
Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
Type 2 Diabetes Mellitus
P4
Completed11RCT, Open-labelIrbesartan/atorvastatin fixed dose combination, Irbesartan SR47436, Atorvastatin
NCT00074984
A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease
Fabry Disease
P4
Completed82RCT, Double-blindFabrazyme (agalsidase beta), Placebo
NCT01895049
Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria
Kidney Transplantation, Cytomegalovirus
P4
Completed171RCT, Open-labelInduction therapy with Thymoglobulin, prednisone, everolimus and late introduction of tacrolimus, Induction therapy with Thymoglobulin, prednisone, mycophenolate sodium and late introduction of tacrolimus
NCT01135017
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
Atrial Fibrillation
P4
Terminated112RCT, Double-blindDronedarone, Placebo (for Dronedarone)
NCT00390884
Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.
Influenza
P4
Completed173Open-labelInfluenza Virus Vaccine, Fluzone®, Influenza Virus Vaccine, Fluzone®
NCT02201004
TOFO Insulin Combination Trial
Type 2 Diabetes Mellitus
P4
Completed211RCT, Double-blindTOFOGLIFLOZIN CSG452, insulin, placebo
NCT00881270
Dermacyd Infantile - Acceptability.
Hygiene
P4
Completed31Open-labelLACTIC ACID(ND)
NCT00518427
Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
Diabetes Type 2
P4
Completed26Open-labelInsulin Glargine
NCT00457249
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
Pertussis, Tetanus
P4
Completed1,564RCT, Double-blindADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed, DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed
NCT00489190
APIDRA Registration Study
Diabetes Mellitus, Type 1
P4
Completed45Open-labelInsulin Glulisine
NCT00761670
Efficacy Study on Cognitive Functions in Schizophrenic Patients
Schizophrenia
P4
Completed37RCT, Open-labelamisulpride and risperidone
NCT02864927
Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea
Meningitis, Meningococcal Meningitis
P4
Completed1,311Open-labelMeningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
NCT00413361
The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS
Systemic Lupus Erythematosus
P4
Completed543RCT, Double-blindversus hydroxychloroquine
NCT00564187
Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice
Hypertension
P4
Completed115RCT, Open-labelIrbesartan, Irbesartan
NCT04410965
Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks
Multiple Sclerosis
P4
Completed82Open-labelTERIFLUNOMIDE
NCT00360139
Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy
Lipodystrophy, Emaciation
P4
Withdrawn15RCT, Open-label
NCT00790387
Tirofiban and Enoxaparin in High Risk Coronary Intervention
Acute Coronary Syndrome
P4
Completed60RCT, Open-labelEnoxaparin, Tirofiban, unfractionated heparin
NCT00255021
Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand
Diphtheria, Tetanus
P4
Completed186Open-labelDiphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vac
NCT00637715
Once Daily Given Alfuzosin in the Treatment of BPH
Benign Prostatic Hyperplasia
P4
Completed60Open-labelAlfuzosin
NCT05929651
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
Meningococcal Immunisation, Healthy Volunteers
P4
Completed71Open-labelMenACYW conjugate vaccine
NCT00431522
Valproic Acid Sodium Salt in Bipolar Disorder
Bipolar Disorder
P4
Completed58Open-labelValproic acid, sodium salt
NCT01311557
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Tetanus, Diphtheria
P4
Completed1,302Open-labelAdacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed, Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed
NCT00132951
KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
Respiratory Tract Infections, Chronic Bronchitis
P4
Terminated2,051RCT, Double-blindTelithromycin, Azithromycin
NCT02006225
Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients.
Autologous Stem Cell Transplantation
P4
Unknown30Open-labelPlerixafor
NCT00799838
Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients
Pharyngotonsillitis
P4
Terminated106RCT, Double-blindKetoprofen, Placebo (for Ketoprofen), Amoxicillin
NCT01981967
Post-licensure Safety Study of IMOJEV® in Thailand
Japanese Encephalitis
P4
Completed10,000Open-labelIMOJEV®: Live attenuated Japanese encephalitis chimeric virus vaccine, IMOJEV®: Live attenuated Japanese encephalitis chimeric virus vaccine
NCT00881374
Dermacyd Infantile (Lactic Acid)- Compatibility.
Hygiene
P4
Completed50Open-labelLACTIC ACID(ND)
NCT00638118
Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen
Allergic Rhinitis
P4
Completed48RCT, Double-blindFexofenadine
NCT01202474
Apidra Children & Adolescents Study
Diabetes Mellitus, Type 1
P4
Completed100Open-labelINSULIN GLULISINE, INSULIN GLARGINE
NCT00850603
Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®
Meningococcal Infections, Meningitis
P4
Completed170RCT, Open-labelMeningococcal Polysaccharide Groups A\C\Y\W-135 Combined, Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined, Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined, Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined, Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined
NCT00648453
Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function
Peripheral Arterial Disease
P4
Completed39Open-labelClopidogrel (Plavix)
NCT02954692
A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
Type 2 Diabetes Mellitus
P4
Completed112Open-labelINSULIN GLARGINE (U300), metformin, sulfonylurea, meglitinides, thiazolidinediones, alpha-glucosidase inhibitors, GLP1 Receptor Agonist, Dipeptidyl peptidase-IV (DPP-IV) inhibitors, Sodium-glucose transport-2 (SGLT-2) inhibitors
NCT00979628
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes, Hyperglycemia
P4
Completed375RCT, Open-labelsliding scale regular insulin (SSRI), Basal Bolus, Basal Plus
NCT00836953
Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®
Influenza
P4
Completed33Open-labelInfluenza virus vaccine (Pediatric formulation)
NCT01107756
A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen
Neoplasms (no Otherwise Specified)
P4
Completed403Open-labelLENOGRASTIM (GRANOGYTE 34)
NCT00077753
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization
Venous Thromboembolism
P4
Completed4,726RCT, Double-blindenoxaparin sodium
NCT00077805
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
Acute Ischemic Stroke
P4
CompletedRCT, Open-labelEnoxaparin sodium
NCT00699920
Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks
Malaria
P4
Completed413RCT, Open-labelCoarsucam, Coartem
NCT01757574
Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)
Chronic Inflammatory Demyelinating Neuropathy
P4
WithdrawnOpen-labelAlemtuzumab infusion
NCT01437423
Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Diphtheria, Tetanus
P4
Completed600Open-labelTETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
NCT00831675
Study of Safety and Immunogenicity of Fluzone® in Healthy Children
Influenza
P4
Completed30Open-labelInfluenza Vaccine 2004-2005 Paediatric Formulation, Influenza Vaccine 2004-2005 Paediatric Formulation
NCT06716424
A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes
P4
Completed105Open-labeliGlarLixi (insulin glargine/lixisenatide)
NCT02526550
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX
Encephalitis
P4
Completed50Open-labelLive attenuated chimeric Japanese Encephalitis vaccine, Inactivated Hepatitis A vaccine
NCT01496313
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
Thyroid Cancer
P4
Completed81RCT, Double-blind300mg vandetanib, 150mg vandetanib
NCT00077818
Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)
Acute Coronary Syndrome
P4
CompletedRCT, Open-labelEnoxaparin sodium
NCT00245674
SOLIACS: Solian Solution in the Acute Setting
Schizophrenia
P4
Completed300Open-labelamisulpride
NCT00911625
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Type 2 Diabetes, Renal Insufficiency
P4
Completed114RCT, Open-label0.5 units/kg daily insulin, 0.25 units/kg daily insulin
NCT00129870
CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer
Colorectal Cancer
P4
Terminated180RCT, Open-labeloxaliplatin
NCT00701129
An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease
Pompe Disease, Glycogen Storage Disease Type II
P4
Completed4Open-labelAlglucosidase Alfa, Methotrexate, Rituximab
NCT00230217
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
Tumors, Hyperuricemia
P4
Completed94Open-labelRasburicase (SR29142)
NCT04075513
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
P4
Completed343RCT, Open-labelInsulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting insulin analogs
NCT00585182
Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
Obesity, Venous Thrombosis
P4
Completed28Open-labelEnoxaparin 0.5 mg/kg once daily
NCT00174824
Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients
Diabetes Mellitus, Type 2
P4
Completed1,024RCT, Open-labelInsulin glargine
NCT01650779
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Fabry Disease
P4
Completed15Open-labelAgalsidase beta
NCT01430819
Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults
Influenza
P4
Completed300RCT, Double-blindInfluenza Virus Vaccine: Fluzone® 2011-2012 Formulation, Influenza Virus Vaccine: Fluzone® High-Dose 2011-2012 Formulation
NCT00601835
Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
Diphtheria, Tetanus
P4
Completed3,651RCT, Double-blindTetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine, Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine
NCT01825382
Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes: the REMOTE-T1D Study, a Pilot Study
Type 1 Diabetes
P4
Completed100RCT, Open-label
NCT00642915
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
Diabetes Mellitus
P4
Completed100Open-labelLantus, Amaryl
NCT00563849
Leflunomide + Methotrexate in Rheumatoid Arthritis
Rheumatoid Arthritis
P4
Completed74Open-labelLeflunomide
NCT01629589
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
Tetanus, Diphtheria
P4
Completed423RCT, Open-labelTetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®)
NCT00454272
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
Infection, Febrile Neutropenia
P4
Completed197RCT, Open-labelTeicoplanin, Vancomycin
NCT01430611
Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children
Meningococcal Disease, Meningitis
P4
Completed666RCT, Single-blindMeningococcal (Groups A and C) Polysaccharide Vaccine, Meningococcal (Groups A and C) Polysaccharide Vaccine
NCT00653302
Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)
Type 2 Diabetes
P4
Completed280Open-labelLantus (insulin glargine) + Glucophage (Metformin)
NCT00627471
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)
Type 2 Diabetes
P4
Terminated9RCT, Open-labelInsulin Glargine, Insulin Glargine
NCT05047718
Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19
Covid19
P4
Completed54Open-labelCOVID-19 vaccine Pfizer (3 doses), COVID-19 vaccine Pfizer (2 doses), COVID-19 mRNA Vaccine Moderna (3 doses), COVID-19 mRNA Vaccine Moderna (2 doses), COVID-19 mRNA Vaccine Moderna (1 dose)
NCT02915302
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Influenza
P4
Completed1,950RCT, Single-blindFluzone Quadrivalent vaccine, No Preservative, Fluzone Quadrivalent vaccine, No Preservative
NCT01665807
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine
Influenza, Vaccination Site Reactions (HT)
P4
Completed868RCT, Open-labelIntanza, Vaxigrip
NCT00288223
Telithromycin in Acute Exacerbation of Chronic Bronchitis
Bronchitis, Chronic
P4
Terminated54Open-labelTelithromycin
NCT00334581
Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
Hypertension
P4
Completed192RCT, Open-labelIrbesartan, Irbesartan
NCT00651911
Fasturtec TLS Treatment / Prophylysis
Tumor Lysis Syndrome
P4
Completed45Open-labelurate oxidase
NCT03485677
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3
Gaucher's Disease Type I, Gaucher's Disease Type III
P3
Completed57Open-labelEliglustat GZ385660, Imiglucerase GZ437843
NCT00174629
GILT Docetaxel - Non-Small Cell Lung Cancer
Lung Neoplasms
P3
Completed449RCT, Open-labelDocetaxel/DDP, docetaxel/gemcitabine
NCT00772928
Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™
Diphtheria, Tetanus
P3
Completed1,167RCT, Open-labelPentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®, Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®
NCT00356967
Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation
Smoking
P3
Completed602RCT, Double-blinddianicline
NCT02787551
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Type 2 Diabetes Mellitus
P3
Completed514RCT, Open-labelInsulin glargine/lixisenatide fixed ratio combination, liraglutide, exenatide, exenatide extended-release, albiglutide, dulaglutide, Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor)
NCT00221637
Efficacy of Valproate in Peripheral Neuropathic Pain
Neuralgia, Neuropathic Peripheral Pain
P2P3
Terminated40RCT, Double-blindSodium Valproate
NCT00362336
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
Hepatitis B, Polio
P3
Completed622RCT, Open-labelDTaP-IPV-HB-PRP~T, CombAct-HIB®, Engerix B® Pediatric
NCT00855530
Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder
Major Depressive Disorders
P3
Completed527Open-labelamibegron (SR58611A)
NCT00670228
Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction
AMI
P3
Terminated34RCT, Open-labelInsulin Glargine (LANTUS), Insulin Glulisine (Apidra), Standard Therapy
NCT00139295
Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee
Osteoarthritis, Knee
P3
CompletedRCT, Double-blind
NCT00452725
Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome
Noonan Syndrome
P3
Completed36Open-labelMAXOMAT ®, biosynthetic growth hormone
NCT01252355
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Multiple Sclerosis Relapse
P3
Terminated534RCT, Double-blindTeriflunomide, Placebo (for teriflunomide), Interferon-beta (IFN-beta)
NCT01515748
Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer
Gastric Cancer
P3
Completed530RCT, Open-labelDocetaxel (XRP6976), Oxaliplatin (SR96669), S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil)
NCT00577421
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO
Postmenopausal Osteoporosis
P3
Completed32Open-labelrisedronate
NCT01121822
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)
Influenza
P3
Completed129Open-labelInfluenza virus vaccine (split virion, inactivated), Influenza virus vaccine (split virion, inactivated)
NCT00924573
Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride
Type 2 Diabetes Mellitus
P3
Completed189RCT, Double-blindMetformin, placebo, Glimepiride (HOE490)
NCT00264927
Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Inappropriate ADH Syndrome, Hyponatremia
P3
Completed77RCT, Double-blindSR121463B
NCT00265642
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
Hepatitis C, Chronic
P3
Completed166RCT, Double-blindIrbesartan, placebo
NCT00785590
Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.
Hygiene
P3
Completed26Open-labelDermacyd PH_DETINLYN (Lactic Acid)
NCT00976027
Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older
Influenza
P3
Terminated9,172RCT, Double-blindTrivalent inactivated influenza vaccine High Dose, Trivalent inactivated influenza vaccine
NCT02992418
Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects
Dengue Fever, Dengue Hemorrhagic Fever
P3
Terminated688RCT, Open-labelCYD Dengue Vaccine, Tdap: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine adsorbed, Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed
NCT03282240
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
Influenza
P3
Completed2,670RCT, Double-blindQIV-HD, Licensed TIV-HD1, Investigational TIV-HD2
NCT01954394
Open Label Study of Long Term Safety Evaluation of Alirocumab
Hypercholesterolemia
P3
Completed986Open-labelAlirocumab, Lipid-Modifying Therapy (LMT)
NCT05468320
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
P3
Completed51Open-labelCaplacizumab, Corticosteroids, anti-CD20 antibody
NCT00519285
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
Prostatic Neoplasms, Neoplasm Metastasis
P3
Completed1,224RCT, Double-blindAflibercept, Placebo (for aflibercept), Docetaxel, Prednisone or Prednisolone
NCT00397098
Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder
Anxiety Disorders
P3
Terminated257RCT, Double-blindSR58611A
NCT01712984
Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years
Influenza
P3
Completed3,360RCT, Double-blindInfluenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation, Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone® Intradermal, Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone Intradermal
NCT04142242
Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49
Meningococcal Infection (Healthy Volunteers)
P3
Completed471RCT, Open-labelMeningococcal Polysaccharide (serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
NCT01646554
Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases
Colorectal Cancer Metastatic, Liver Metastases
P2P3
WithdrawnRCT, Open-labelModified FOLFOX6, Aflibercept
NCT01683266
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
P3
Completed549RCT, Open-labelHOE901-U300 (Insulin glargine new formulation), Lantus (Insulin glargine)
NCT02012998
Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA
Virus Diseases, Hepatitis B
P3
Completed751Open-labelHBVAXPRO 5µg
NCT00554333
Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine
Influenza
P3
Completed795RCT, Open-labelFlu-ID 15μg, Inactivated adjuvanted Influenza Vaccine
NCT00397553
Insulin Glulisine, Diabetes Mellitus Type 1
Diabetes Mellitus, Type 1
P3
Completed104Open-labelInsulin glulisine
NCT00272051
XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
Metastases, Colorectal Neoplasms
P3
Completed620RCT, Double-blindSR57746A
NCT00318448
Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Attention Deficit Hyperactivity Disorder
P3
Completed201RCT, Double-blindZolpidem (SL800750)
NCT02234323
An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A
Hemophilia A
P3
Completed108Open-labelrFVIIIFc
NCT07079670
Safety and Immunogenicity of NVX-CoV2705
COVID-19, SARS-CoV-2 Infection
P3
Completed676Open-labelNVX-CoV2705
NCT01676220
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Type 2 Diabetes Mellitus
P3
Completed878RCT, Open-labelHOE901-U300 (new formulation of insulin glargine), Lantus (insulin glargine)
NCT00261703
Docetaxel in Head and Neck Cancer
Head and Neck Neoplasms
P2P3
Completed439RCT, Open-labelDocetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy, Cisplatin, 5-fluorouracil (5-FU), radiotherapy
NCT00546325
REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents
Diabetes Mellitus, Type 2
P3
Completed358RCT, Double-blindRimonabant, Placebo
NCT00912925
Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I
Mucopolysaccharidosis I, Hurlers Syndrome
P3
Completed45RCT, Double-blindrhIDU (recombinant human-Alpha-L-Iduronidase), Placebo
NCT00803049
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
P3
Completed742RCT, Double-blindTeriflunomide (HMR1726)
NCT04478084
Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland
Rabies (Healthy Volunteers)
P3
Completed403RCT, Double-blindPurified vero rabies vaccine - serum free VRVg-2, Purified inactivated rabies vaccine, Equine rabies immunoglobulins (ERIG) (only Group 3 and Group 4), Human rabies immunoglobulins (HRIG) (only Group 5 and Group 6)
NCT01346293
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
Tetanus, Diphtheria
P3
Completed3,372RCT, Open-labelDiphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus, Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus, Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus, Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus
NCT03549871
A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis
Hemophilia
P3
Completed80Open-labelFitusiran, BPA prophylaxis, Factor (FVIII or FIX) prophylaxis
NCT00327444
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Ovarian Neoplasms, Ascites
P2P3
Completed58RCT, Double-blindaflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®), Placebo, aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
NCT00576667
An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes
Fatty Liver
P3
Terminated165RCT, Double-blindRimonabant, Placebo (for Rimonabant)
NCT04544267
Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age
Influenza
P3
Terminated100RCT, Double-blindQuadrivalent influenza vaccine, high-dose, Quadrivalent influenza vaccine, standard dose
NCT00622700
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Multiple Sclerosis
P3
Completed618RCT, Double-blindTeriflunomide, Placebo
NCT01027364
Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B
Severe Hemophilia B
P3
Completed123Open-labelFactor IX (rFIXFc), rFIX
NCT02234310
Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B
Hemophilia B
P3
Completed33Open-labelrFIXFc
NCT00077844
Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)
Percutaneous Coronary Intervention
P2P3
Completed3,532RCT, Open-labelEnoxaparin sodium
NCT00206713
Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim
Crohn Disease
P3
Terminated264RCT, Double-blindSargramostim (Leukine), Placebo
NCT00132925
An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis
Rhinitis, Allergic, Perennial
P3
Completed460RCT, Double-blindTriamcinolone
NCT01768559
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
Type 2 Diabetes
P3
Completed894RCT, Open-labelLixisenatide (AVE0010), Insulin glulisine QD, Insulin glulisine TID, Insulin Glargine (Mandatory background drug), Metformin (Background drug)
NCT00766688
Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia
Hypercholesterolemia
P3
Terminated643RCT, Double-blindAVE5530, Placebo
NCT04681729
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
Cold Urticaria
P3
Completed82RCT, Double-blindDupilumab SAR231893, Placebo, Non sedating H1-antihistamine
NCT04492254
Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients
COVID-19
P3
Terminated219RCT, Open-labelEnoxaparin
NCT00454402
ALF-STONE: Alfuzosin in Uretheric Stones
Prostatic Hyperplasia
P3
Terminated220RCT, Double-blindAlfuzosin
NCT00619957
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
Other Osteoporosis
P3
Completed285RCT, Double-blindPlacebo tablet, Risedronate
NCT00434681
Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
Fever, Pain
P3
Completed48Open-labelparacetamol 4.8% paediatric oral suspension
NCT00309556
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Breast Cancer
P3
Completed536RCT, Open-labelEpirubicin, Docetaxel, Capecitabine, Trastuzumab
NCT00316329
ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria
Malaria
P3
Completed1,032RCT, Single-blindArtesunate + Amodiaquine
NCT00312377
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
Non-small Cell Lung Cancer, Lung Cancer
P3
Completed1,690RCT, Double-blindDocetaxel, Vandetanib
NCT00785681
Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Compatibility
Hygiene
P3
Completed53Open-labelDermacyd PH_DETINBACK (Lactic Acid)
NCT00712673
GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Diabetes Mellitus, Type 2
P3
Completed680RCT, Double-blindLixisenatide (AVE0010), Placebo, Metformin
NCT00705276
Dermacyd Femina Delicata (Lactic Acid)- Photo Dermatological Evaluation of the Irritation and Sensitivity Potential
Hygiene
P3
Completed26Open-labelLactic acid (Dermacyd Femina Delicata)
NCT00458718
Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch
Smoking Cessation
P3
Completed755RCT, Double-blindrimonabant (SR141716)
NCT00576823
Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology
Hydronephrosis, Neurogenic Bladder
P3
Completed25Open-labelAlfuzosin
NCT00290979
Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
P3
Completed250RCT, Open-labelinsulin glulisine
NCT03600818
Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
Polymyalgia Rheumatica
P3
Terminated118RCT, Double-blindSarilumab SAR153191 (REGN88), Sarilumab-matching placebo, Prednisone, Prednisone-matching placebo, Prednisone
NCT00754689
Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P3
WithdrawnRCT, Double-blindRimonabant, Metformin, placebo
NCT06705140
A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
RSV Immunisation
P3
Terminated947RCT, Double-blindLow Dose (LD) RSVt vaccine, Standard Dose (SD) RSVt vaccine, High Dose (HD) RSVt vaccine, Placebo
NCT00325390
Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation
Platelet Aggregation Inhibitors, NSTEACS
P3
Completed800RCT, Double-blindclopidogrel (SR25990C)
NCT00353080
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Osteoporosis, Postmenopausal
P3
Completed171RCT, Double-blindrisedronate (HMR4003)
NCT03521934
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Heart Failure, Type 2 Diabetes Mellitus
P3
Terminated1,222RCT, Double-blindSotagliflozin, Placebo
NCT00694122
Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon
Type 1 Diabetes, Dawn Phenomenon
P3
Completed27Open-labelLantus (glargine)
NCT00345098
A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
Depressive Disorder, Major Depression
P3
Completed704RCT, Double-blindSR58611A
NCT00563225
20 Week Bridging Study in Type II DM
Diabetes Mellitus Type II
P3
Completed90Open-labelInsulin Glargine
NCT00284128
AVE7688 in Patients With Mild to Moderate Blood Pressure
Hypertension
P2P3
Completed1,940RCT, Double-blindAVE7688, Losartan-potassium
NCT00531622
An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
Major Depressive Disorder
P3
Completed643RCT, Double-blindsaredutant (SR48968), escitalopram, placebo
NCT00345618
Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
Embolism, Thrombosis
P3
Completed3,202RCT, Double-blindIdrabiotaparinux sodium, Warfarin, Placebo (for idrabiotaparinux sodium), Avidin, Placebo (for warfarin), Enoxaparin
NCT01378286
Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria
Malaria
P3
Completed380RCT, Open-labelARTESUNATE + AMODIAQUINE, Chloroquine
NCT00115570
Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
Diabetes Mellitus, Insulin-Dependent
P3
Completed572RCT, Open-labelInsulin glulisine, insulin lispro, insulin glargine, NPH insulin
NCT01644188
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)
Hypercholesterolemia
P3
Completed720RCT, Double-blindAlirocumab, Placebo (for alirocumab), Ezetimibe, Placebo (for ezetimibe), Lipid Modifying Therapy (LMT)
NCT00418886
Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients
Non Small Cell Lung Cancer, Lung Cancer
P3
Completed698RCT, Double-blindVandetanib, Pemetrexed
NCT00763451
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Diabetes Mellitus, Type 2
P3
Completed484RCT, Double-blindLixisenatide (AVE0010), Placebo, Metformin
NCT05132569
Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
Myasthenia Gravis
P3
Terminated6RCT, Double-blindTolebrutininb, Placebo
NCT00632866
Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Primary Sjögren's Syndrome
P3
Completed120RCT, Double-blindHydroxychloroquine, Placebo
NCT00323778
Prospective Assessment of the Efficacy of Hyaluronate Knee Injections in Patients With Osteoarthritis
Knee Osteoarthritis
P3
Terminated40Open-labelHyalgan
NCT00688740
Docetaxel in Node Positive Adjuvant Breast Cancer
Breast Cancer
P3
Completed1,491RCT, Open-labelDocetaxel, 5-fluorouracil, Doxorubicin, Cyclophosphamide
NCT00326378
Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
P3
Completed434RCT, Open-labelconsolidation chemotherapy with Docetaxel plus cisplatin, CCRT arm without consolidation chemotherapy
NCT02004691
Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency
Sphingomyelin Lipidosis
P2P3
Completed36RCT, Double-blindplacebo (saline), Olipudase alfa
NCT00273546
Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer
Cancer
P3
Completed500RCT, Open-labelXRP6976 (Docetaxel/Taxotere)
NCT00489736
Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
Atrial Fibrillation
P3
Completed504RCT, Double-blinddronedarone (SR33589), amiodarone
NCT00561964
Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria
Hypertension
P3
Completed241RCT, Double-blindIrbesartan, placebo
NCT03762265
A Study of PRN1008 in Patients With Pemphigus
Pemphigus
P3
Terminated131RCT, Double-blindRilzabrutinib, Placebo
NCT03760965
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise
Type 2 Diabetes Mellitus
P3
Terminated276RCT, Double-blindsotagliflozin (SAR439954), placebo
NCT00129935
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
Breast Cancer
P3
Completed1,384RCT, Open-labelDocetaxel, Capecitabine, Epirubicin, Cyclophosphamide
NCT03025789
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Trypanosomiasis, African, Sleeping Sickness
P3
Completed174Open-labelFexinidazole
NCT06641180
Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age
Influenza
P3
Completed1,180RCT, Double-blindHigh-Dose trivalent influenza vaccine (Split virion, Inactivated), Standard-dose trivalent influenza vaccine (Split virion, Inactivated)
NCT00243178
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
Atrial Fibrillation, Vascular Risk
P3
Terminated6,706RCT, Open-labelclopidogrel (SR25990C)
NCT01359449
Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations
Meningitis, Meningococcal Infection
P3
Completed123RCT, Open-labelMeningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®, Meningococcal Group C Conjugate vaccine: MenC
NCT00303316
Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants
Diphtheria, Tetanus
P3
Completed458Open-labelDTaP-IPV//PRP~T combined vaccine, DTaP-IPV//PRP~T combined vaccine
NCT01890759
Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation
Meningitis, Meningococcal Infection
P3
Completed300Open-labelMeningococcal Diphtheria Toxoid Vaccine
NCT03713684
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
Type 2 Diabetes Mellitus
P3
Terminated370RCT, Double-blindEfpeglenatide SAR439977, Placebo, Background therapy
NCT00401531
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants
Hepatitis B, Polio
P3
Completed412RCT, Single-blindDTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines, DTaP-HB-IPV and Pneumococcal polysaccharide vaccines
NCT00932945
Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal
Hygiene
P3
Completed32Open-labelLACTIC ACID(ND)
NCT03156621
Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
Homozygous Familial Hypercholesterolemia
P3
Completed69RCT, Double-blindAlirocumab, Placebo
NCT00103610
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
Lymphoma, Non-Hodgkin
P3
Completed298RCT, Double-blindGranulocyte colony-stimulating factor plus plerixafor, Granulocyte colony-stimulating factor plus placebo
NCT01240746
Study of Quadrivalent Influenza Vaccine Among Children
Influenza
P3
Completed4,363RCT, Double-blindLicensed 2010-2011 Trivalent Influenza Vaccine, No Preservative, Investigational Trivalent Influenza Vaccine with alternate B strain, No Preservative, Quadrivalent Influenza Vaccine, No Preservative
NCT00325546
Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)
Obesity
P3
Completed643RCT, Double-blindRimonabant (SR141716), Placebo
NCT00784160
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility
Hygiene
P3
Completed53Open-labelLactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)
NCT01861730
Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants
Tuberculosis
P1P2
Completed243RCT, Double-blindAERAS-404, Placebo
NCT04491877
Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Respiratory Syncytial Virus Infection
P1P2
Completed259RCT, Double-blindRSV vaccine formulation 1, RSV vaccine formulation 2, Placebo
NCT00771602
Alemtuzumab + Rituximab Consolidation in CLL
Chronic Lymphocytic Leukemia, Leukemia
P2
Terminated1RCT, Open-labelRituximab, Alemtuzumab
NCT03145766
Immunogenicity and Safety of a Purified Vero Rabies Vaccine
Rabies Virus
P2
Completed320RCT, Double-blindVRVg 2, VRVg 1, Imovax Rabies, VRVg 2, VRVg 2, Human Rabies Immunoglobulins (HRIG)
NCT00688883
Fludara (Oral) Phase II Study for Indolent Lymphoma
Lymphoma
P2
Completed52Open-labelFludarabine Phosphate (Fludara)
NCT00542828
Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome
Myelodysplastic Syndrome (MDS)
P2
Terminated16Open-labelThymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG)
NCT03418571
Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection
Respiratory Syncytial Virus Lower Respiratory Tract Infection
P2
Terminated15RCT, Double-blindALX-0171 1.5 mg/kg
NCT00193128
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
Esophagus Cancer
P1P2
Completed59Open-labelOxaliplatin, Docetaxel, Capecitabine
NCT01576029
Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer
Prostatic Neoplasms
P2
Completed2RCT, Open-labelCABAZITAXEL (XRP6258), DOCETAXEL (XRP6976)
NCT00406302
Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)
Carcinoma, Non-small-cell Lung
P2
Completed41Open-labelDocetaxel, oxaliplatin, cetuximab
NCT00830544
Study of Neoadjuvant Chemotherapy of Breast Cancer
Breast Cancer
P2
Unknown54Open-labelNeoadjuvant chemotherapy, Chemotherapy, Neoadjuvant chemotherapy
NCT00461344
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
Ductal Carcinoma
P2
Terminated20Open-labelDocetaxel, Doxorubicin
NCT00811395
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
Multiple Sclerosis
P2
Completed182RCT, Double-blindTeriflunomide, Placebo (for teriflunomide), Interferon-β [IFN-β], Glatiramer Acetate [GA]
NCT01882868
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
Colorectal Cancer Metastatic
P2
Completed62Open-labelAflibercept, Levofolinate, Irinotecan, 5-FU
NCT00181168
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Thyroid Cancer
P2
Completed63RCT, Open-labelEuthyroid Group
NCT00493649
Adj TC + Herceptin Early Stage Breast Cancer
Breast Cancer
P2
Completed493Open-labelTaxotere, Cytoxan, Herceptin
NCT06914908
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study
Chronic Rhinosinusitis With Nasal Polyps
P2
By Invite71Open-labelLunsekimig, Mometasone furoate nasal spray (MFNS)
NCT04398706
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Pneumococcal Immunisation, Diphtheria Immunisation
P2
Completed852RCT, Double-blindPneumococcal Conjugate Vaccine formulation 1, Pneumococcal Conjugate Vaccine formulation 2, Pneumococcal Conjugate Vaccine formulation 3, Varicella Virus Vaccine Live, Measles, Mumps, and Rubella Virus Vaccine Live, Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate), Rotavirus Vaccine, Live, Oral, Pentavalent, Hepatitis B Vaccine* [Recombinant] *as applicable
NCT02812706
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
Multiple Myeloma
P1P2
Completed36Open-labelIsatuximab SAR650984
NCT03594955
First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome
Leukaemia
P1P2
Terminated7Open-labelSAR440234
NCT00816543
Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma
Gastric Cancer
P2
Completed41Open-labelDOCETAXEL, S-1, OXALIPLATIN
NCT01368848
Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
NSCLC
P2
Completed7Open-labelBevacizumab, Cisplatin, Docetaxel
NCT00914277
SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction
Erectile Dysfunction
P2
Completed24RCT, Double-blindSAR407899, Placebo, Sildenafil
NCT00126009
SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients
Bipolar Disorder
P2
Completed120RCT, Open-labelAmisulpride
NCT00982137
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)
Japanese Encephalitis, Yellow Fever
P2
Completed108RCT, Double-blindLive attenuated Japanese encephalitis virus; Yellow fever virus, Yellow fever virus; Live attenuated Japanese encephalitis virus, Live attenuated Japanese encephalitis virus; Yellow fever virus, Live attenuated Japanese encephalitis virus; Yellow fever virus
NCT01531205
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
Prostate Cancer
P2
Terminated2Open-labelAndrogen Ablation, Cabazitaxel, Salvage Therapy, Neoadjuvant Treatment - Hormonal Therapy, Neoadjuvant Treatment - Cabazitaxel
NCT00263354
Oxaliplatin in Gastric Cancer
Stomach Neoplasms
P2
Completed20Open-labelOxaliplatin
NCT00047840
This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
P2
Completed129RCT, Double-blindZD6474, Placebo, Docetaxel
NCT00600249
Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.
Breast Cancer
P2
Completed35Open-labelCetuximab, Docetaxel
NCT03205358
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers
Meningitis, Meningococcal Meningitis
P2
Completed188RCT, Open-labelMeningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal Polysaccharide groups A, C, W-135 and Y Conjugate Vaccine
NCT00206726
Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)
Leukemia, Lymphocytic, Chronic, B-Cell
P2
Completed60Open-labelAlemtuzumab plus Fludarabine
NCT01011049
Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM
Influenza
P2
Completed1,250RCT, Open-labelInfluenza Virus Vaccine USP Trivalent Types A and B, Influenza Virus Vaccine USP Trivalent Types A and B, Influenza Virus Vaccine USP Trivalent Types A and B, Influenza Virus Vaccine USP Trivalent Types A and B
NCT03749148
Cholinergic Urticaria - Efficacy of Dupilumab
Cholinergic Urticaria
P2
Completed48RCT, Double-blindDupilumab, Placebo
NCT02973321
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
P2
Completed296RCT, Double-blindSAR425899, Placebo, Liraglutide, Metformin
NCT02844582
Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Hormone-Resistant Prostate Cancer, Stage IV Prostate Adenocarcinoma
P2
Terminated2Open-labelCabazitaxel, Prednisone
NCT00625755
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma
Renal Cell Carcinoma
P1P2
Completed40Open-labelElectrofusion DC vaccine
NCT00480987
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes, Acute Myeloid Leukemia
P1P2
Terminated27Open-labelOxaliplatin, Fludarabine, Cytarabine
NCT06066255
PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM
Hematological Malignancy
P2
Unknown27Open-labelThymoglobulin Injectable Product
NCT00066313
ZD6474 in Treating Patients With Small Cell Lung Cancer
Lung Cancer
P2
CompletedRCT, Double-blindvandetanib
NCT05179603
A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]
Classic Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma
P2
Terminated14Open-labelTHOR-707, Pembrolizumab
NCT04781816
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus
Cutaneous Lupus Erythematosus
P2
Completed78RCT, Double-blindSAR443122, Placebo
NCT00510107
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
Stomach Neoplasm, Stage IV
P2
Unknown90RCT, Open-labeloxaliplatin, Cisplatin
NCT00491257
A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine
Influenza, Orthomyxoviridae Infections
P2
Completed130Open-labelInactivated influenza vaccine (split virion) NH 2007-2008 formulation
NCT00098345
Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
Thyroid Cancer
P2
Completed40Open-labelZD6474 (vandetanib)
NCT01661972
Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
P1P2
Completed63Open-labelCapecitabine and aflibercept
NCT00991172
A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain
Sciatica
P2
Completed159RCT, Double-blindREGN475, REGN475, Placebo Injection
NCT00950066
Irbesartan and Amlodipine Combination in Controlling Blood Pressure
Hypertension
P2
Completed270RCT, Double-blindIRBESARTAN (SR47436), Amlodipine, Irbesartan / Amlodipine, Placebo
NCT02287922
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis
Rheumatoid Arthritis
P2
Completed251RCT, Double-blindALX-0061, Placebo, Tocilizumab
NCT00504257
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
Fallopian Tube Cancer, Ovarian Cancer
P2
Completed45Open-labelAvastin, Docetaxel
NCT01258595
A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age
Influenza
P2
Completed300RCT, Double-blindHigh-Dose Trivalent Inactivated Influenza Vaccine, Trivalent Inactivated Influenza Vaccine
NCT00133731
The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention
Angioplasty, Transluminal, Percutaneous Coronary
P2
Completed947RCT, Double-blindOtamixaban (XRP0673), Unfractionated Heparin
NCT00611962
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin
Neoplasms, Germ Cell and Embryonal
P2
Completed27Open-labelOxaliplatin, Paclitaxel
NCT00382720
Docetaxel and Oxaliplatin in Gastric Cancer
Stomach Neoplasms
P2
Completed275RCT, Open-labelDocetaxel + Oxaliplatin, Docetaxel + Oxaliplatin + 5-FU, Docetaxel + Oxaliplatin + Capecitabine
NCT00924443
A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable
Acute Myeloid Leukemia
P2
Completed69Open-labelclofarabine
NCT00851084
Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer
Colorectal Neoplasms, Neoplasm Metastasis
P2
Completed268RCT, Open-labelaflibercept, oxaliplatin, 5-FU, Folinic Acid
NCT00464633
Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
Leukemia, Lymphocytic, Chronic
P2
Completed165Open-labelalvocidib
NCT00988143
A Study of Influenza Virus Vaccines in Children and Adults
Influenza
P2
Completed600RCT, Open-label2009-2010 Trivalent Influenza Virus Vaccine, 2008-2009 Trivalent Influenza Virus Vaccine, Quadrivalent Influenza Virus Vaccine
NCT01574326
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease
Hyperphosphatemia, Chronic Kidney Disease
P2
Completed101RCT, Double-blindPlacebo, Sevelamer carbonate
NCT03159143
Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract
Metastatic Transitional Cell Cancer of the Urothelial Tract
P2
Completed22Open-labelDocetaxel, Oxaliplatin
NCT05018806
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis
P2
Completed124RCT, Double-blindPlacebo, Rilzabrutinib
NCT02435121
A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification
Neoplasm Malignant
P2
Completed1Open-labelSAR125844
NCT00322491
Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
Lymphoma, Non-Hodgkin, Multiple Myeloma
P2
Completed49Open-labelG-CSF Plus Plerixafor
NCT01463397
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
Neuropathic Pain
P2
Completed191RCT, Double-blindSAR292833, placebo
NCT00226460
Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
Parkinson's Disease
P2
CompletedRCT, Double-blindFetal porcine cells, Neurocell-PD
NCT03284710
Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
HIV Infections
P1P2
Completed132RCT, Double-blindALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Bivalent Subtype C gp120 admixed with Al(OH)3 Suspension, Bivalent Subtype C gp120
NCT01963598
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
Sarcopenia
P2
Completed253RCT, Double-blindREGN1033 (SAR391786), placebo
NCT03530267
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer
Colorectal Cancer
P2
Completed124RCT, Open-labelAflibercept + mLV5FU2, mFOLFOX7
NCT00174798
MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.
Overactive Bladder
P2
Completed118RCT, Double-blindSSR240600C, Placebo, Tolterodine
NCT00952003
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
Gastric Cancer, Unresectable
P2
Completed40Open-labelOxaliplatin, Irinotecan, Bevacizumab, Docetaxel
NCT04270942
At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)
Diabetes Mellitus, Type 1
P2
Completed6Open-labelteplizumab 1 mg/mL
NCT04394624
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)
Non-small Cell Lung Cancer Metastatic
P2
Terminated31Open-labelSAR408701, ramucirumab, pembrolizumab
NCT00669370
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
Stomach Neoplasms
P2
Unknown50Open-labeldocetaxel and capecitabine
NCT00988897
Colorectal Cancer RECHALLENGE
Colorectal Neoplasms
P2
WithdrawnOpen-labelOXALIPLATIN (SR96669), 5-FLUOROURACIL (5-FU), LEUCOVORIN (LV), BEVACIZUMAB
NCT00875524
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects
Dengue Virus, Dengue Fever
P2
Completed180RCT, Double-blindCYD dengue vaccine serotypes (1, 2, 3, 4)., Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
NCT01034995
A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder
Major Depression
P2
Completed580RCT, Double-blindSSR125543, escitalopram, placebo
NCT00580073
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
Rectal Cancer
P2
Terminated6Open-labelFOLFOX4, Cetuximab
NCT00494481
E3 Breast Cancer Taxotere Combination
Advanced Breast Cancer
P2
Completed64RCT, Double-blindVandetanib (ZD6474), Docetaxel
NCT01025154
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
Acute Myeloid Leukemia
P2
Completed63Open-labelClofarabine, Idarubicin, Cytarabine
NCT03367819
Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies
Prostate Cancer, Non-small Cell Lung Cancer
P1P2
Terminated44RCT, Open-labelIsatuximab SAR650984, Cemiplimab REGN2810
NCT04424927
PRV-015 in Gluten-free Diet Non-responsive Celiac Disease
Celiac Disease
P2
Completed388RCT, Double-blindPRV-015
NCT00356122
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
P2
Completed53Open-labelDocetaxel, Oxaliplatin, Bevacizumab
NCT03203642
Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD
Autosomal Dominant Polycystic Kidney, ADPKD
P2
Completed80RCT, Double-blindTesevatinib, Placebo
NCT01440179
SAR3419 in Acute Lymphoblastic Leukemia
Acute Lymphocytic Leukaemia
P2
Terminated100Open-labelSAR3419
NCT00504491
R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukaemia, Patients Resistant to a Purine Analogous
P2
WithdrawnOpen-labelRituximab-CHOP-Alemtuzumab
NCT00297596
Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
Breast Cancer
P2
Completed25Open-labelTrastuzumab, Oxaliplatin
NCT01669720
Adjuvant Aflibercept for Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
P2
Terminated10RCT, Open-labelAflibercept
NCT01173497
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer
P2
Completed44Open-labelINIPARIB + irinotecan
NCT00209092
Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer
Breast Cancer
P2
Completed51RCT, Open-labelDocetaxel, Capecitabine
NCT00235300
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Cadaveric Donor Renal Transplantation, Acute Renal Allograft Rejection
P2
Completed240RCT, Open-labelThymoglobulin [Anti-thymocyte Globulin (rabbit)], Simulect (basliximab)
NCT00903760
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndrome
P2
Completed42RCT, Open-labelDecitabine, Clofarabine
NCT02331927
PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
P2
Unknown150RCT, Open-labelAflibercept
NCT06444451
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata
Alopecia Areata
P2
Terminated166RCT, Double-blindAmlitelimab, Placebo
NCT00268710
Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]
Prostatic Neoplasms
P2
CompletedOpen-labeldocetaxel
NCT06454240
A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
P2
Completed79RCT, Double-blindlunsekimig, placebo
NCT00315705
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
P1P2
Completed50Open-labelclofarabine, Etoposide, Cyclophosphamide
NCT00311129
Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
Lymphoma, Low-Grade
P2
Completed41RCT, Open-labelFludarabine Phosphate (Fludara), Rituximab
NCT00303056
Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis
Joint Disease
P2
Completed590RCT, Double-blindHOE140 Icatibant
NCT00508001
Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)
Carcinoma, Hepatocellular
P2
Completed67RCT, Double-blindVandetanib, Vandetanib, Best Supportive Care
NCT06609239
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Asthma
P2
By Invite900Open-labelLunsekimig
NCT00813956
A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer
Triple Negative Breast Cancer
P2
Completed80Open-labelgemcitabine plus carboplatin plus BSI-201
NCT00442169
Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
West Nile Fever
P2
Completed208RCT, Double-blindChimeriVax-WN02 Low Dose, ChimeriVax-WN02 Medium Dose, ChimeriVax-WN02 High Dose, 0.9% Saline solution, ChimeriVax-WN02 High Dose, 0.9 % NaCl solution
NCT00434668
Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
P2
Completed99RCT, Open-labelcisplatin/docetaxel, cisplatin/vinorelbine
NCT03279289
Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen
Metastatic Colorectal Cancer
P2
Completed170RCT, Open-labelAflibercept, Irinotecan, folinic acid (dl racemic), 5Fluorouracil, 5-FU
NCT00239174
A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients
Obesity
P2
Completed394RCT, Double-blindSR147778
NCT00396591
AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites
Ovarian Neoplasms
P2
Completed16Open-labelAflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
NCT00117650
Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication
Intermittent Claudication, Peripheral Vascular Disease
P2
Completed289RCT, Double-blindAd2/HIF-1α/VP16, Ad2/HIF-1α/VP16, Ad2/HIF-1α/VP16
NCT06067425
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia
Osteochondrodysplasia
P2
Terminated16RCT, Open-labelSAR442501
NCT00074958
A Study of Fabrazyme in Pediatric Patients With Fabry Disease
Fabry Disease
P2
Completed16Open-labelFabrazyme (agalsidase beta)
NCT06949358
A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France
Acid Sphingomyelinase Deficiency
P2
Completed3Open-labelOlipudase alfa
NCT02040636
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis
Pertussis, Tetanus
P2
Completed277RCT, Open-labelTetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV, Hepatitis B vaccine
NCT00475865
Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
Multiple Sclerosis
P2
Completed123RCT, Double-blindTeriflunomide, Placebo (for teriflunomide), Glatiramer Acetate (GA)
NCT00228163
Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
Multiple Sclerosis
P2
Completed147RCT, Open-labelteriflunomide (HMR1726)
NCT00217282
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
P2
Completed45Open-labeloxaliplatin, gemcitabine, bevacizumab
NCT00771849
Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children
Meningitis, Meningococcemia
P2
Completed103RCT, Double-blindMeningococcal Polysaccharide Diphtheria Toxoid Conjugate, Haemophilus Influenzae Type b (Hib) vaccine
NCT00774878
Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer
Breast Neoplasms
P2
Terminated18RCT, Open-labelAVE1642, Fulvestrant
NCT00612677
Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem
Lung Cancer
P2
Terminated1Open-labelOxaliplatin, Pemetrexed
NCT00043706
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
Systemic Sclerosis, Scleroderma
P1P2
CompletedHuman Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody
NCT05071053
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer
Adenocarcinoma Gastric, Gastrooesophageal Cancer
P2
Terminated35Open-labelRamucirumab (CYRAMZA®), Tusamitamab ravtansine (SAR408701)
NCT00101075
Title XELOX FOR SALIVARY GLAND CANCERS
Head and Neck Cancer
P2
Terminated9Open-labelCapecitabine, Oxaliplatin
NCT01511536
Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer
Prostate Cancer
P1P2
Completed38Open-labelCabazitaxel XRP6258, Abiraterone acetate, Prednisone 5 mg
NCT00174616
CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision
Rectal Neoplasms
P2
Completed87Open-labelOxaliplatin, capecitabine, radiotherapy
NCT00343239
Docetaxel in Locally Advanced Gastric Adenocarcinoma
Stomach Neoplasms
P2
Completed59Open-labelDocetaxel, Cisplatin, Fluorouracil
NCT00842530
Efficacy and Safety of Dengue Vaccine in Healthy Children
Dengue Virus, Dengue Fever
P2
Completed4,002RCT, Double-blindCYD Dengue Vaccine, Inactivated rabies virus vaccine, Placebo
NCT03546907
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease
P2
Completed343RCT, Double-blindSAR440340, Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as standard of care, Any Long Acting Beta Agonist as prescribed by treating physician as standard of care, Any Long Acting Muscarinic Agonist as prescribed by treating physician as standard of care, Any short-acting β agonist as prescribed by treating physician as standard of care
NCT02694718
A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer
Rectal Cancer
P2
Completed60Open-labelCapecitabine, Oxaliplatin
NCT00526110
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
Gastrointestinal Diseases
P1P2
Completed98Open-label5-Fluorouracil, Docetaxel, Oxaliplatin
NCT05450562
Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors
Neoplasm
P1P2
Terminated33Open-labelSAR444200, Atezolizumab
NCT00298675
Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors
Tumors
P1
Completed59Open-labelBSI-201 (iniparib), irinotecan
NCT01673737
A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
Neoplasm Malignant
P1
Completed75Open-labelSAR260301, Vemurafenib
NCT00170053
Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids
Kidney Diseases
P1
Completed177Open-labelSirolimus
NCT00716716
Phase I/IIa Study of FIXFc in Hemophilia B Patients
Hemophilia B
P1
Completed10Open-labelrFIXFc
NCT01839526
A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
Fabry Disease
P1
Terminated39Open-labelIohexol
NCT01146678
Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1
Type 1 Diabetes Mellitus
P1
Completed22RCT, Open-labelInsulin glargine HOE901, Lixisenatide AVE0010
NCT00486135
Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma
Cancer, Lymphoma
P1
Completed118Open-labelXL147 (SAR245408), XL147 (SAR245408)
NCT01390818
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Locally Advanced Solid Tumor, Metastatic Solid Tumor
P1
Completed146Open-labelMSC1936369B (pimasertib), SAR245409 (PI3K and mTOR inhibitor), MSC1936369B (pimasertib), SAR245409 (PI3K and mTOR inhibitor)
NCT00981240
Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes
Acute Myelogenous Leukemia
P1
Completed30Open-labelSAR103168
NCT00496509
Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer
Colorectal Cancer
P1
Completed24RCT, Open-labelZD6474 (Zactima) 100mg, ZD6474 (Zactima) 300mg
NCT01465646
Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets
Pharmacokinetics
P1
Completed24RCT, Open-labellevothyroxine, levothyroxine
NCT05845996
Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult Subjects
Healthy Volunteers
P1
Completed56RCT, Double-blindSAR441344, placebo, Keyhole limpet hemocyanin
NCT05844735
A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566
Rheumatoid Arthritis
P1
Completed60RCT, Double-blindSAR441566, Placebo, Ciprofloxacin
NCT00254826
Yellow Fever Virus Vaccine and Immune Globulin Study
Viremia
P1
Completed80RCT, Double-blindYF-VAX® plus saline, 17D YF Vaccine plus Ig,
NCT04521738
First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects
Overweight, Healthy Subjects
P1
Completed48RCT, Double-blindSAR441255, placebo
NCT06193304
A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth
Gaucher's Disease
P1
Completed6Open-labelEliglustat
NCT01657214
Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients
Neoplasm Malignant
P1
Completed70Open-labelSAR125844
NCT02049203
Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis
Aortic Valve Stenosis
P1
Completed44RCT, Double-blindAtaciguat, Placebo
NCT04770935
To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)
Von Willebrand's Disease (VWD)
P1
Completed6Open-labelefanesoctocog alfa (BIVV001)
NCT04748926
Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants
Healthy Volunteers
P1
Completed24RCT, Open-labelrilzabrutinib SAR444671, rilzabrutinib SAR444671, rilzabrutinib SAR444671
NCT01444352
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
Pneumococcal Infections, Streptococcus Pneumoniae Infections
P1
Completed100RCT, Double-blindPneumococcal vaccine Formulation 1, Pneumococcal vaccine Formulation 2, Pneumococcal vaccine Formulation 3, Placebo
NCT01193595
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Neoplasms, Malignant
P1
Completed39Open-labelOmbrabulin (AVE8062), bevacizumab
NCT00559429
Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
Prostate Cancer
P1
Completed13Open-labelDocetaxel, Docetaxel, Docetaxel, Docetaxel
NCT01785329
Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects
Hypercholesterolemia
P1
Completed60RCT, Open-labelalirocumab SAR236553 (REGN727)
NCT01074372
Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers
Healthy Volunteers
P1
Completed32RCT, Double-blindREGN727, Placebo
NCT01561781
Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib
Healthy Volunteers
P1
Completed14Open-labelDigoxin, Vandetanib
NCT00125827
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors
Solid Tumors
P1
Completed24Open-labelclofarabine (oral formulation)
NCT04333654
Hydroxychloroquine in Outpatient Adults With COVID-19
Coronavirus Infection
P1
Terminated8RCT, Double-blindHydroxychloroquine SAR321068, Placebo
NCT06118151
Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older
Influenza, Influenza Immunization
P1
Completed388RCT, Double-blindInfluenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant Influenza Vaccine
NCT02803918
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes Mellitus
P1
Completed23RCT, Single-blindLixisenatide (AVE0010), Placebo, Basal Insulin, Metformin
NCT01463488
Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I
Knee Osteoarthritis
P1
Completed24RCT, Double-blindSAR113945, placebo
NCT05918614
A Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female Subjects
Immune System Disorder (Healthy Volunteer)
P1
Completed8RCT, Double-blindBelumosudil mesylate, Placebo
NCT01197391
Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers
Healthy
P1
Completed48RCT, Double-blindREGN728
NCT03310944
Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
P1
Completed12RCT, Open-labelsotagliflozin (SAR439954)
NCT01484600
Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN668 Administered Subcutaneously to Healthy Volunteers
Healthy
P1
Completed36RCT, Open-labelREGN668: Injection Rate 1, REGN668: Injection Rate 2
NCT00916110
Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects
Healthy
P1
Completed72RCT, Double-blindATN-103, ATN-103, ATN-103, ATN-103, ATN-103, ATN-103, ATN-103, ATN-103, ATN-103
NCT02101073
ALX-0061 Phase I Bioavailability Study in Healthy Volunteers
Rheumatoid Arthritis
P1
Completed70Open-labelALX-0061, ALX-0061
NCT01063946
A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor
Neoplasms, Malignant
P1
Completed3Open-labelOmbrabulin (AVE8062)
NCT02422654
Taste Evaluation of Different Liquid Formulations With Eliglustat
Gaucher Disease
P1
Completed8RCT, Single-blindeliglustat
NCT01340157
Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions
PK in Healthy Volunteers
P1
Completed12RCT, Open-labelFexinidazole
NCT05795907
Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants
Amyotrophic Lateral Sclerosis (Healthy Volunteers)
P1
Completed84RCT, Double-blindSAR443820, Placebo
NCT02283775
SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients
Plasma Cell Myeloma
P1
Completed54Open-labelIsatuximab SAR650984, Pomalidomide, Dexamethasone
NCT04802057
Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088
Autoimmune Haemolytic Anaemia
P1
Terminated9Open-labelSAR445088
NCT02536937
A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate
Gaucher Disease
P1
Completed32Open-labeleliglustat
NCT01544140
Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib
Healthy Volunteers
P1
Completed16Open-labelMidazolam, vandetanib
NCT00692900
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Ovarian Cancer, Peritoneal Cancer
P1
Completed25Open-labelintravenous docetaxel with intraperitoneal oxaliplatin, intravenous oxaliplatin with intraperitoneal docetaxel
NCT01483911
ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers
RSV Infection
P1
Completed60RCT, Double-blindALX-0171, Placebo
NCT01015027
Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers
Healthy
P1
Completed48RCT, Double-blindREGN668
NCT00297583
Insulin Glulisine in Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
P1
CompletedRCT, Double-blindInsulin Glulisine
NCT06106074
Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult Participants
Multiple Sclerosis
P1
Completed71RCT, Double-blindTolebrutinib, Placebo
NCT01041508
Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.
Leukemia Lymphoblastic, Acute, Acute Myeloid Leukemia
P1
Completed18Open-labelClofarabine, Cyclosporine, Mycophenolate Mofetil
NCT01723735
Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects
Hypercholesterolemia
P1
Completed79RCT, Open-labelAlirocumab, Ezetimibe, Ezetimibe Placebo, Fenofibrate
NCT01636479
Phase 1 Safety Testing of SAR405838
Neoplasm Malignant
P1
Completed77Open-labelSAR405838
NCT00282581
Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive
HIV Infections, Smallpox
P1
Terminated2RCT, Double-blindMVA Smallpox Vaccine
NCT07272629
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
Cardiac Repolarization, Healthy Volunteers
P1
Completed48RCT, Double-blindBalinatunfib, Moxifloxacin, Placebo
NCT01349855
Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
P1
Completed30RCT, Double-blindInsulin glargine HOE901
NCT00479076
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
Neoplasms
P1
Completed22RCT, Open-labelaflibercept (AVE0005), S-1
NCT04982991
Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants
Multiple Sclerosis Healthy Subjects
P1
Completed14Open-labelRIPK1 inhibitor
NCT07071558
Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age
Respiratory Syncytial Virus Immunization
P1
Completed240RCT, Double-blindRSV vaccine formulation 1 dose, RSV vaccine formulation 2 dose, RSV vaccine formulation 3 dose, RSV vaccine formulation 4 dose, RSV vaccine formulation 5 dose, RSV vaccine formulation 6 dose, RSV vaccine formulation 7 dose, RSV vaccine formulation 8 dose
NCT06444204
A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)
Hepatic Function Abnormal, Healthy Volunteers
P1
Completed29Open-labelRilzabrutinib
NCT03634982
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Solid Tumors
P1
Unknown133Open-labelRMC-4630
NCT05839626
A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)
Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis
P1
Terminated32RCT, Open-labelSAR445514
NCT01909843
ALX-0171 Safety Study in Adults With Hyperresponsive Airways
Respiratory Syncytial Virus Infection
P1
Completed24Open-labelALX-0171
NCT04045795
Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
P1
Completed56RCT, Open-labelisatuximab SAR650984 IV, pomalidomide, dexamethasone, isatuximab SAR650984 SC
NCT01233895
Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma
Multiple Myeloma
P1
Completed26RCT, Open-labelAVE1642, Velcade
NCT02395237
COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.
Healthy
P1
WithdrawnRCT, Open-label: Amaryl® M IR 2/1000
NCT04189029
PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study
Heart Failure, Heart Failure With Preserved Ejection Fraction
Unknown175
NCT01693302
Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
Type 1 Diabetes
N/A
Completed23RCT, Open-label
NCT00728364
Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy
Focus of Study: Prevalence of Fabry Disease in CKD Population
Completed4,353
NCT02824068
Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study)
Pompe Disease
Completed112glucosidase alfa
NCT00212849
Autologous Chondrocyte Implantation in the Patellofemoral Joint
Chondrosis, Patellar Articular Cartilage Lesions
Completed35
NCT05819125
Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin
Venous Thromboembolism
Terminated21,000
NCT03954717
Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program
Multiple Sclerosis
Completed111
NCT00665730
Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions
Abdominal Adhesions
N/A
Terminated5RCT, Single-blind
NCT00709293
Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients
Ischemia Reperfusion Injury, Heart Transplantation
N/A
WithdrawnRCT, Double-blindAnti-Thymocyte Globulin, Normal Saline
NCT03147898
Observational Study Describing the Immune Profile Induced By Pertussis Vaccines
Whooping Cough, Pertussis
Completed90
NCT01764152
Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02)
Adult Hospitalized
N/A
Completed450Open-label
NCT01659294
Diabetes Outcomes and Nurse Case Manager Study
Type 2 Diabetes
N/A
Completed140RCT, Open-label
NCT01010464
An Adhesion Reduction Plan in the Management of the Surgical Open Abdomen
Open Abdomen
N/A
WithdrawnRCT, Open-label
NCT03406663
The Korean TITRATION Study: Comparison of the Self-titration Methods for Glargine-300
Type 2 Diabetes Mellitus
N/A
Completed130RCT, Open-label
NCT00804284
Database Surveillance Safety Study of PENTACEL® Vaccine
Diphtheria, Tetanus
Completed62,538DTaP-IPV/Hib, Other DTap Vaccines
NCT04958070
The Intensively Follow-up Examinations for Asymptomatic MPS I Infants in Taiwan
MPS I
Unknown20
NCT01237314
The Impact of Food on Blood Sugar in People With Type 2 Diabetes
Type 2 Diabetes
Completed46
NCT05075499
Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab
Multiple Sclerosis
N/A
Unknown70Open-labelCOVID-19 vaccination
NCT03643328
Ex Vivo Evaluation of Immunity Activation Face to S. Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
Staphylococcus Aureus
N/A
Completed50Open-labelblood samples, nasal swabs
NCT04997772
Digital Health Platform Customized for Patients With Gaucher Disease
Gaucher Disease, Patient Reported Outcome
Completed80
NCT07411638
Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients
Acne
Not Yet Recruiting200
NCT05442645
A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan
Atopic Dermatitis
Completed80
NCT00337181
Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
HIV-1
Completed114
NCT02580669
Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis
Progressive Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
N/A
Terminated70Open-label
NCT00995748
The RECORD Asia-Pacific Atrial Fibrillation Registry
Atrial Fibrillation
Completed2,674
NCT01165697
Establishment of Biomarkers for Fabry Disease
Fabry Disease
Completed4
NCT04057859
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training
Cancer of the Prostate
Completed271
NCT00716352
Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes
Acute Coronary Syndromes, Coronary Artery Disease
N/A
Completed1,340RCT
NCT05906706
Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid
Bullous Pemphigoid
APPROVED_FOR_MARKETINGdupilumab
NCT05629260
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
Hematological Malignancy
Unknown300ATG, Post-transplantation cyclophosphamide
NCT02061124
Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota
Type 2 Diabetes
N/A
Completed50RCT, Double-blindSevelamer 1600 mg TID for 7 days, Placebo 1600 mg TID for 7 days
NCT00394524
Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU
Diabetes or With New Hyperglycemia
N/A
Completed160RCT, Open-label
NCT07663136
Finding Immune Nascent Type 1 Diabetes
Healthy Adult, Type 1 Diabetes (T1D)
N/A
Not Yet Recruiting3,800RCT, Open-label
NCT01929473
Seroepidemiological Study of Pertussis and Other Infectious Diseases
Pertussis Infection
Completed3,830
NCT00971074
Study of Viscosupplementation for the Treatment of Knee Pain After Menisectomy
Arthralgia
N/A
WithdrawnRCT, Double-blindHylan G-F 20
NCT04430881
A National Study in Patients With Unexplained Splenomegaly
Gaucher Disease, Splenomegaly
Completed506
NCT05622331
Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in Sweden
Respiratory Syncytial Virus (RSV)
Completed1,100,000
NCT01206712
Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients
Diabetes Mellitus, Type 2
Completed106
NCT00992251
Eligard Observational Registry for Patients With Prostate Cancer
Cancer of the Prostate
Completed354
NCT00275717
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
Kidney Transplant
Completed60
NCT00270712
A Study of Factors That Affect Long-Term Kidney Transplant Function
Kidney Transplant
Completed3,175
NCT02207075
Measuring Active Microglia in Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
Completed50[C11]PK-1195 PET scan
NCT00748839
Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical
Heparin-induced Thrombocytopenia
Completed2,700
NCT07692217
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Hemophilia A, Factor VIII (FVIII)
Not Yet Recruiting60Half-life factor VIII based replacement therapy, Non-FVIII based replacement therapy
NCT05687474
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
Completed6,824
NCT04725669
Seroprevalence of Pertussis Among Children and Adolescents in Croatia
Immunogenicity, Vaccine
N/A
Unknown1,500Open-label
NCT04173442
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
Atopic Dermatitis (AD), Asthma
Completed581dupilumab
NCT02672137
Knowledge Translation for Patients With Acute Coronary Syndromes
Acute Coronary Syndromes
N/A
Completed4,604RCT, Open-label
NCT01043757
Financial Incentives for Increasing Exercise
Sedentary Lifestyle, Obesity
N/A
WithdrawnRCT, Double-blind
NCT01104740
Dengue Seroprevalence Study in Blood Donors in the French West Indies
Blood Donors, Dengue
Completed817
NCT02490982
Teriflunomide Observational Effectiveness Study
Relapsing Remitting Multiple Sclerosis
Completed106Teriflunomide
NCT01737372
A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis
Multiple Sclerosis, Secondary Progressive Multiple Sclerosis
Completed49
NCT00248352
A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery Disease
Diabetes Mellitus, Type 2, Coronary Disease
N/A
Completed169RCT, Open-label
NCT00344825
Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)
Leukemia, B-Cell, Chronic
Completed300Alemtuzumab (MabCampath, BAY86-5045) and Fludarabine Phosphate (Fludara, BAY86-4864)
NCT03492489
Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
NO_LONGER_AVAILABLEcemiplimab
NCT03197597
EUpertstrain 4 Study of Bordetella Pertussis Isolates
Bordetella Pertussis, Whooping Cough
Completed265
NCT00582309
Comparative Trial Between 3 Types of Insulin Infusion Protocols
Hyperglycemia
N/A
Completed151RCT, Open-label
NCT02890147
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
Healthy Subjects
Completed649
NCT03694392
Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years
Influenza, Pneumonia
Completed2,776,278Flublok Quadrivalent, Standard Dose Inactivated Influenza Vaccine (SD-IIV)
NCT06258577
Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency
Gaucher Disease
Not Yet Recruiting50
NCT01747759
Evaluation of a Preoperative Education in Total Knee Arthroplasty
Knee Osteoarthritis (Knee OA)
N/A
Completed44RCT, Double-blind
NCT00186940
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Leukemia, Lymphoma
Completed16Rasburicase